MedTrace Logo

BiLirubin Decrease Under Phototherapy Exposure in the Preterm Newborn in Incubator

NCT03942757 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2020-03-23

No results posted yet for this study

Summary

Phototherapy is routinely used in neonatal intensive care units for the treatment of jaundice. Guidelines focus mainly on bilirubin serum levels to start the phototherapy. Only few data are available about clinical management of phototherapy devices and subsequently the impact on bilirubin serum decrease. Especially there are no strong recommendations about phototherapy duration, irradiance measurements, incubator temperature and humidity settings. Various factors can influence irradiance and thus the preterm infant bilirubin serum decrease. This study aims at evaluating the impact of an educational program on the use and efficacy of phototherapy in a neonatal intensive care unit.

Conditions

  • Preterm Infant
  • Jaundice, Neonatal
  • Phototherapy

Interventions

OTHER

bilirubin serum level determination

bilirubin serum level before and after phototherapy treatment will be measured

OTHER

Phototherapy

Preterm infant \< 35 weeks of gestation with a jaundice requiring phototherapy according to NICE guidelines can be included for the duration of the phototherapy treatment.

Sponsors & Collaborators

  • Centre Hospitalier Universitaire, Amiens

    lead OTHER

Eligibility

Max Age
1 Day
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-05-02
Primary Completion
2020-03-19
Completion
2020-03-19

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03942757 on ClinicalTrials.gov